Since the discovery of the human T-cell leukemia virus-1 (HTLV-1), cellular and animal
models have provided invaluable contributions in the knowledge of viral infection …

Hematological malignancy is a disease arisen by complicate reasons that seriously
endangers human health. The research on its pathogenesis and therapies depends on the …

Human T-cell lymphotropic virus type-1 (HTLV-1) has a large global burden and in some key
communities, such as Indigenous Australians living in remote areas, greater than 45% of …

We investigated the impact of monocytes, NK cells, and CD8+ T-cells in primary HTLV-1
infection by depleting cell subsets and exposing macaques to either HTLV-1 wild type …

Infection with human T-cell leukemia/lymphoma virus type 1 (HTLV-1) has been associated
with various clinical syndromes including co-infection with Strongyloides stercoralis, which is …

Human T-cell leukemia virus type 1 (HTLV-1) is a complex human delta retrovirus that
infects an estimated 10–20 million people worldwide (Gessain and Cassar 2012). HTLV-1 …

The human T cell leukemia virus type 1 (HTVL-1), first reported in 1980 by Robert Gallo's
group, is the etiologic agent of both cancer and inflammatory diseases. Despite …

Bcl-xL represents a family of proteins responsible for the regulation of the intrinsic apoptosis
pathway. Due to its anti-apoptotic activity, Bcl-xL co-determines the viability of various virally …

Viral and parasitic coinfections are known to lead to both enhanced disease progression
and altered disease states. HTLV-1 and Strongyloides stercoralis are co-endemic …

Human T-cell leukemia virus type 1 (HTLV-1) is the causal agent of adult T-cell
leukemia/lymphoma and HTLV-1-associated myelopathy/tropical spastic paraparesis. Its …